Clinical Study of Camrelizumab Combined With SOX in the Adjuvant Treatment of Advanced Gastric Adenocarcinoma or Gastric Esophageal Junction Adenocarcinoma

NCT05184946 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Camrelizumab Combined with SOX

Sponsor

The Second Affiliated Hospital of Shandong First Medical University